• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仿生纳米技术在 SARS-CoV-2 治疗中的应用。

Biomimetic Nanotechnology for SARS-CoV-2 Treatment.

机构信息

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China.

出版信息

Viruses. 2023 Feb 21;15(3):596. doi: 10.3390/v15030596.

DOI:10.3390/v15030596
PMID:36992304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051120/
Abstract

More than 600 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in the pandemic of coronavirus disease 2019 (COVID-19). In particular, new waves of COVID-19 caused by emerging SARS-CoV-2 variants pose new health risks to the global population. Nanotechnology has developed excellent solutions to combat the virus pandemic, such as ACE2-based nanodecoys, nanobodies, nanovaccines, and drug nanocarriers. Lessons learned and strategies developed during this battle against SARS-CoV-2 variants may also serve as inspiration for developing nanotechnology-based strategies to combat other global infectious diseases and their variants in the future.

摘要

全球已有超过 6 亿人感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2),导致 2019 年冠状病毒病(COVID-19)大流行。特别是由新型 SARS-CoV-2 变异株引起的 COVID-19 新一波浪潮给全球人口带来了新的健康风险。纳米技术为抗击病毒大流行提供了出色的解决方案,例如基于 ACE2 的纳米诱饵、纳米抗体、纳米疫苗和药物纳米载体。在这场抗击 SARS-CoV-2 变异株的战斗中吸取的经验教训和制定的策略也可能为未来开发基于纳米技术的策略提供灵感,以应对其他全球传染病及其变异株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f6/10051120/134df4821111/viruses-15-00596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f6/10051120/7827ff4b9c46/viruses-15-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f6/10051120/134df4821111/viruses-15-00596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f6/10051120/7827ff4b9c46/viruses-15-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f6/10051120/134df4821111/viruses-15-00596-g002.jpg

相似文献

1
Biomimetic Nanotechnology for SARS-CoV-2 Treatment.仿生纳米技术在 SARS-CoV-2 治疗中的应用。
Viruses. 2023 Feb 21;15(3):596. doi: 10.3390/v15030596.
2
Nanotechnology-based strategies against SARS-CoV-2 variants.基于纳米技术对抗新冠病毒变异株的策略。
Nat Nanotechnol. 2022 Oct;17(10):1027-1037. doi: 10.1038/s41565-022-01174-5. Epub 2022 Aug 18.
3
Nanotechnologies for the Diagnosis and Treatment of SARS-CoV-2 and Its Variants.用于诊断和治疗严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的纳米技术。
Small Methods. 2023 Jul;7(7):e2300034. doi: 10.1002/smtd.202300034. Epub 2023 May 15.
4
Nanomedicine approaches against SARS-CoV-2 and variants.纳米医学方法对抗 SARS-CoV-2 及其变体。
J Control Release. 2024 Jan;365:101-111. doi: 10.1016/j.jconrel.2023.11.004. Epub 2023 Nov 22.
5
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.纳米技术对抗 COVID-19:免疫、诊断和治疗研究。
J Control Release. 2021 Aug 10;336:354-374. doi: 10.1016/j.jconrel.2021.06.036. Epub 2021 Jun 25.
6
Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article.牛源抗体和骆驼源纳米抗体作为针对 SARS-CoV-2 及其变体的生物治疗武器:一篇综述文章。
Int J Surg. 2022 Feb;98:106233. doi: 10.1016/j.ijsu.2022.106233. Epub 2022 Jan 19.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2.利用 SARS-CoV-2 的生物学和化学特性了解和抗击 COVID-19。
Bioprocess Biosyst Eng. 2022 Nov;45(11):1753-1769. doi: 10.1007/s00449-022-02788-8. Epub 2022 Sep 20.
9
Nanotechnology-Based Strategies for the Management of COVID-19: Recent Developments and Challenges.基于纳米技术的 COVID-19 管理策略:最新进展与挑战。
Curr Pharm Des. 2021;27(41):4197-4211. doi: 10.2174/1381612827666210830105459.
10
Recent Patents and Advances on Nanotechnologies against Coronavirus.近期冠状病毒纳米技术专利及进展
Recent Pat Nanotechnol. 2021;15(4):322-330. doi: 10.2174/1872210514666201110125536.

引用本文的文献

1
Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications.仿生纳米载体:整合天然功能以实现高级治疗应用
Beilstein J Nanotechnol. 2024 Dec 16;15:1619-1626. doi: 10.3762/bjnano.15.127. eCollection 2024.
2
Nature-inspired innovations: unlocking the potential of biomimicry in bionanotechnology and beyond.受自然启发的创新:释放生物纳米技术及其他领域中仿生学的潜力。
Discov Nano. 2024 Nov 21;19(1):186. doi: 10.1186/s11671-024-04153-y.
3
Bacterial Membrane Vesicles as a Novel Vaccine Platform against SARS-CoV-2.

本文引用的文献

1
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.广谱中和且能提供保护作用的纳米抗体,可对抗 SARS-CoV-2 奥密克戎变异株 BA.1、BA.2、BA.4/5 和多种沙贝科病毒。
Nat Commun. 2022 Dec 27;13(1):7957. doi: 10.1038/s41467-022-35642-2.
2
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination.奥密克戎变异株可逃避 2 年 COVID-19 恢复期患者对 SARS-CoV-2 的持续特异性抗体应答,而无论其是否接种疫苗。
Emerg Microbes Infect. 2023 Dec;12(1):2151381. doi: 10.1080/22221751.2022.2151381.
3
细菌膜囊泡作为一种新型 SARS-CoV-2 疫苗平台。
Curr Microbiol. 2024 Aug 20;81(10):317. doi: 10.1007/s00284-024-03846-y.
4
Functionally Designed Nanovaccines against SARS-CoV-2 and Its Variants.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变体的功能设计纳米疫苗。
Vaccines (Basel). 2024 Jul 12;12(7):764. doi: 10.3390/vaccines12070764.
5
Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses.蛋白质纳米颗粒作为人类和人畜共患病毒的疫苗平台。
Viruses. 2024 Jun 9;16(6):936. doi: 10.3390/v16060936.
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
镶嵌 RBD 纳米颗粒可预防多种沙贝科病毒在动物模型中的攻击。
Science. 2022 Aug 5;377(6606):eabq0839. doi: 10.1126/science.abq0839.
4
Monoclonal antibody therapies against SARS-CoV-2.针对 SARS-CoV-2 的单克隆抗体疗法。
Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5.
5
Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections.腹腔 M2 巨噬细胞衍生的细胞外囊泡作为天然多靶点纳米治疗剂,可减轻严重感染后的细胞因子风暴。
J Control Release. 2022 Sep;349:118-132. doi: 10.1016/j.jconrel.2022.06.063. Epub 2022 Jul 6.
6
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants.四价马赛克六聚 HexaPro 嵌合纳米颗粒疫苗可预防 SARS-CoV-2 变体感染。
Nat Commun. 2022 May 13;13(1):2674. doi: 10.1038/s41467-022-30222-w.
7
Circular RNA vaccines against SARS-CoV-2 and emerging variants.环状 RNA 疫苗对抗 SARS-CoV-2 及新兴变种。
Cell. 2022 May 12;185(10):1728-1744.e16. doi: 10.1016/j.cell.2022.03.044. Epub 2022 Apr 1.
8
Emerging mRNA technologies: delivery strategies and biomedical applications.新兴的 mRNA 技术:递药策略和生物医学应用。
Chem Soc Rev. 2022 May 23;51(10):3828-3845. doi: 10.1039/d1cs00617g.
9
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy.一种用于抗原呈递和免疫抑制逆转的纳米疫苗,作为一种个性化癌症免疫治疗策略。
Nat Nanotechnol. 2022 May;17(5):531-540. doi: 10.1038/s41565-022-01098-0. Epub 2022 Apr 11.
10
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody.吸入型双特异性单域抗体对 SARS-CoV-2 变体的广泛中和作用。
Cell. 2022 Apr 14;185(8):1389-1401.e18. doi: 10.1016/j.cell.2022.03.009. Epub 2022 Mar 10.